Stay updated on Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 reference were removed.
    Difference
    0.1%
    Check dated 2025-12-17T22:04:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Publications section text was updated to clarify auto-fill from PubMed, and the revision/version numbers were updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T08:26:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the study page, which previously directed users to official status pages for operating updates.
    Difference
    0.4%
    Check dated 2025-11-19T07:56:09.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    New entries appear in the Study Record Dates showing Results First Submitted (2024-05-13), Results First Submitted that Met QC Criteria (2025-01-07), and Results First Posted (2025-02-03).
    Difference
    0.5%
    Check dated 2025-10-28T02:55:15.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T15:55:49.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added new oncology-related terms and upgraded revision to v3.1.0; removed the Liver Cancer topic and old v3.0.2 revision.
    Difference
    1%
    Check dated 2025-09-29T09:52:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.